HPBCD is the active component in a triple combination formulation for treatment of Niemann-Pick C1 disease
Niemann-Pick type C1 (NPC1) disease is a fatal neurovisceral disease for which there are no FDA approved treatments, though cyclodextrin
Category: Drug delivery
World Congress on Chemistry
“World Congress on Chemistry” during October 24-25, 2019, at Valencia, Spain. WCC-2019 provides a forum for in-depth assessment of the
Annual World Congress of Nano Science & Technology-2019
9th Annual World Congress of Nano Science & Technology-2019 (Nano S&T-2019) will be held in Suzhou, China from October 20-22,
Drug in CD in liposome for targeted delivery of anti-tubercular drugs
Nkanga and Krause have published in Nature Scientific Reports their recent development of a novel anti-tubercular drug delivery system. Isoniazid-hydrazone-phthalocyanine
Efficient Grafting of Cyclodextrin to Alginate and Performance of the Hydrogel for Release of Model Drug
Controlling the rate of release of molecules from a hydrogel is of high interest for various drug delivery systems and
17th Annual Congress of International Drug Discovery Science and Technology
The 17th Annual Congress of International Drug Discovery Science and Technology-2019 (IDDST-China 2019) will take place in Nanjing, China on
International Pharmacology and Pharmaceutical Sciences Conference
The “International Pharmacology and Pharmaceutical Sciences Conference (OLCPPSC-2019)” which is going to be held during November 14-15, 2019 at Venice, Italy.
New clinical trial with cyclodextrins on hernia treatment
A new clinical trial with a rather innovative use of cyclodextrins is about to start shortly, although the recruitment has
Folate-Decorated Amphiphilic Cyclodextrins as Cell-Targeted Nanophototherapeutics
The group of Prof. Mazzaglia published on a ternary nanoassembly (SAP) composed of nonionic amphiphilic β-cyclodextrins (amphiphilic CD) incorporating pheophorbide
Polymeric Nanoparticles as Promising Tool for Anti-cancer Therapeutics
Polymeric Nanoparticles as Promising Tool for Anti-cancer Therapeutics (edited by Prashant Kesharwani, Kishore Paknikar and Virendra Gajbhiye) and published by